Type 1 diabetes induced by immune checkpoint inhibitors.

In conclusions, ICI-induced type 1 diabetes is a potentially life-threating adverse event after the immunotherapy of cancers. Screening and early recognition is important. Further investigation of the mechanism may help to better understand the pathology of type 1 diabetes. PMID: 32842016 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32842016?dopt=Abstract

Source: Chinese Medical Journal - August 23, 2020 Category: General Medicine Authors: Zhang R, Cai XL, Liu L, Han XY, Ji LN Tags: Chin Med J (Engl) Source Type: research